Buys
Open market- Shares
- +48,544
- Avg price
- $2.06
- Total value
- +$100,001
Lee T. Schalop - Director at Lantern Pharma Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- Director
- Issuer symbol
- LTRN on Nasdaq
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
Lee T. Schalop - trading volume in the past year for Lantern Pharma Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +48,544
- Share %
- 100%
- Total value
- +$100,001
Holdings reported by Lee T. Schalop for Lantern Pharma Inc.
Form 4 holding
Director
Lantern Pharma Inc.
- Security class
- Common stock, $0.001 par value
- Shares / value
- 48,544
- Estimated value
- $100,000
- Report date
- 12 May 2026
- Price
- $2.06
- Ownership
- Direct
Form 4 holding
Director
Lantern Pharma Inc.
- Security class
- Common stock purchase warrant (Right to Buy)
- Shares / value
- 48,544
- Estimated value
- Report date
- 12 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Lantern Pharma Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 18,460
- Estimated value
- Report date
- 09 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Lee T. Schalop for Lantern Pharma Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.